Exelixis (EXEL) Insider Trading & Ownership $35.61 +0.78 (+2.24%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exelixis (NASDAQ:EXEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.85%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$15.27 MNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$21.65 M Get EXEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Exelixis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EXEL Insider Buying and Selling by Quarter Ad Darwin2025: Digital Asset Insights You Need to KnowCryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! Exelixis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/18/2024Patrick J HaleyEVPSell41,588$34.36$1,428,963.68 11/5/2024Dana AftabEVPSell96,986$35.00$3,394,510.00 11/1/2024George PosteDirectorSell30,000$34.00$1,020,000.00 11/1/2024Jeffrey HessekielEVPSell50,000$34.13$1,706,500.00 10/30/2024Dana AftabEVPSell1,162$31.40$36,486.80 10/28/2024Jeffrey HessekielEVPSell25,000$28.39$709,750.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/23/2024Jeffrey HessekielEVPSell25,000$26.38$659,500.00 8/26/2024Jeffrey HessekielEVPSell20,000$25.79$515,800.00 8/14/2024Maria C FreireDirectorSell8,250$26.56$219,120.00 8/12/2024Dana AftabEVPSell20,883$27.06$565,093.98 8/9/2024Christopher J SennerCFOSell125,000$27.19$3,398,750.00 8/8/2024George PosteDirectorSell33,725$26.89$906,865.25 8/7/2024Dana AftabEVPSell95,000$25.00$2,375,000.00 6/4/2024Jack L WyszomierskiDirectorSell8,287$22.00$182,314.00 5/30/2024David Edward JohnsonDirectorBuy225,000$20.76$4,671,000.00 5/28/2024David Edward JohnsonDirectorBuy200,000$20.32$4,064,000.00 5/21/2024George PosteDirectorSell11,686$20.96$244,938.56 5/13/2024Jack L WyszomierskiDirectorSell10,923$21.37$233,424.51 3/21/2024Alan M GarberDirectorSell19,205$24.01$461,112.05 2/23/2024Patrick J HaleyEVPSell47,020$21.45$1,008,579.00 2/21/2024David Edward JohnsonDirectorBuy190,000$20.70$3,933,000.00 12/14/2023Patrick J HaleyEVPSell50,000$23.35$1,167,500.00 12/12/2023Patrick J HaleyEVPSell14,149$22.50$318,352.50 12/4/2023Jeffrey HessekielEVPSell25,000$22.06$551,500.00 11/30/2023Jeffrey HessekielEVPSell25,000$22.01$550,250.00 11/27/2023David Edward JohnsonDirectorBuy120,409$21.61$2,602,038.49 (Data available from 1/1/2013 forward) EXEL Insider Trading Activity - Frequently Asked Questions Who is on Exelixis's Insider Roster? The list of insiders at Exelixis includes Alan M Garber, Carl B Feldbaum, Christopher J Senner, Dana Aftab, David Edward Johnson, George Poste, Jack L Wyszomierski, Jeffrey Hessekiel, Lance Willsey, Maria C Freire, Patrick J Haley, Peter Lamb, and Stelios Papadopoulos. Learn more on insiders at EXEL. What percentage of Exelixis stock is owned by insiders? 2.85% of Exelixis stock is owned by insiders. Learn more on EXEL's insider holdings. Which Exelixis insiders have been buying company stock? The following insider purchased EXEL shares in the last 24 months: David Edward Johnson ($15,270,038.49). How much insider buying is happening at Exelixis? Insiders have purchased a total of 735,409 EXEL shares in the last 24 months for a total of $15,270,038.49 bought. Which Exelixis insiders have been selling company stock? The following insiders have sold EXEL shares in the last 24 months: Alan M Garber ($1,160,712.05), Carl B Feldbaum ($711,200.00), Christopher J Senner ($4,629,350.00), Dana Aftab ($6,474,627.78), George Poste ($2,839,003.81), Jack L Wyszomierski ($669,871.51), Jeffrey Hessekiel ($7,899,618.40), Maria C Freire ($219,120.00), Patrick J Haley ($4,989,175.69), and Peter Lamb ($317,600.00). How much insider selling is happening at Exelixis? Insiders have sold a total of 1,231,827 Exelixis shares in the last 24 months for a total of $29,910,279.24 sold. Exelixis Key ExecutivesDr. Stelios Papadopoulos Ph.D. (Age 76)Co-Founder & Chair of the Board Compensation: $118.25kDr. Michael M. Morrissey Ph.D. (Age 63)CEO, President & Director Compensation: $2.16MMr. Christopher J. Senner (Age 56)Executive VP & CFO Compensation: $1.06M1 recent tradesDr. Dana T. Aftab Ph.D. (Age 60)Executive VP of Discovery and Translational Research & Chief Scientific Officer Compensation: $883.03kMr. Jeffrey J. Hessekiel J.D. (Age 55)Executive VP, General Counsel & Secretary Compensation: $933.08k4 recent tradesDr. Amy C. Peterson M.D. (Age 57)Executive VP, Product Development & Medical Affairs and Chief Medical Officer Compensation: $568.85kMs. Susan T. HubbardExecutive Vice President of Public Affairs & Investor RelationsMs. Laura DillardExecutive Vice President of Human ResourcesDr. Anne Champsaur M.D.Senior Vice President of Drug SafetyDr. William Berg M.D.Senior Vice President of Medical Affairs More Insider Trading Tools from MarketBeat Related Companies Charles River Laboratories International Insider Trades Medpace Insider Trades ICON Public Insider Trades National Research Insider Trades Precigen Insider Trades Alnylam Pharmaceuticals Insider Trades Biogen Insider Trades United Therapeutics Insider Trades Incyte Insider Trades Neurocrine Biosciences Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:EXEL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.